WuXi PharmaTech has Adopted Optive Research's Benchware
Mar 18, 2004
March 18, 2004 – Shanghai, China –Recently WuXi PharmaTech has adopted Optive Research's Benchware, a software helping our medical chemists on library making, designing, and exploring. Optive Research (www.optive.com) was an renowned software developer for Computer-Assisted Drug Discovery. And its software is now widely used at major pharmaceutical research facility in the world. Using Benchware enables WuXi PharmaTech to reduce molecular discovery cycle times and synthesize higher quality lead compounds, thereby achieving more predictable discovery processes for our partners.
About WuXi PharmaTech (Cayman) Inc. WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: www.wuxiapptec.com.